FINWIRES · TerminalLIVE
FINWIRES

Immunovant Insider Sold Shares Worth $1,532,309, According to a Recent SEC Filing

By

Jay S Stout, Chief Technology Officer, on June 26, 2026, sold 40,000 shares in Immunovant (IMVT) for $1,532,309. Following the Form 4 filing with the SEC, Stout has control over a total of 211,685 common shares of the company, with 211,685 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401326000074/xslF345X05/wk-form4_1782517552.xml

Related Articles